In this multiple-hit hypothesis of AD, APOE4 carriers with chronic unresolved tissue inflammation, for example from eicosanoid lipidome activation, have a greater risk of developing AD dementia [34, 35]. This evidence concerns the gene APOE and Alzheimer disease.